Global Infantile Spasm Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Infantile Spasm Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Infantile Spasm Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Infantile Spasm Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Infantile Spasm Treatment Market Perspective (2015-2026)
2.2 Infantile Spasm Treatment Growth Trends by Regions
2.2.1 Infantile Spasm Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Infantile Spasm Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Infantile Spasm Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Infantile Spasm Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Infantile Spasm Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Infantile Spasm Treatment Players by Market Size
3.1.1 Global Top Infantile Spasm Treatment Players by Revenue (2015-2020)
3.1.2 Global Infantile Spasm Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Infantile Spasm Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Infantile Spasm Treatment Market Concentration Ratio
3.2.1 Global Infantile Spasm Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Infantile Spasm Treatment Revenue in 2019
3.3 Infantile Spasm Treatment Key Players Head office and Area Served
3.4 Key Players Infantile Spasm Treatment Product Solution and Service
3.5 Date of Enter into Infantile Spasm Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Infantile Spasm Treatment Historic Market Size by Type (2015-2020)
4.2 Global Infantile Spasm Treatment Forecasted Market Size by Type (2021-2026)
5 Infantile Spasm Treatment Breakdown Data by Application (2015-2026)
5.1 Global Infantile Spasm Treatment Market Size by Application (2015-2020)
5.2 Global Infantile Spasm Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Infantile Spasm Treatment Market Size (2015-2020)
6.2 Infantile Spasm Treatment Key Players in North America (2019-2020)
6.3 North America Infantile Spasm Treatment Market Size by Type (2015-2020)
6.4 North America Infantile Spasm Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Infantile Spasm Treatment Market Size (2015-2020)
7.2 Infantile Spasm Treatment Key Players in Europe (2019-2020)
7.3 Europe Infantile Spasm Treatment Market Size by Type (2015-2020)
7.4 Europe Infantile Spasm Treatment Market Size by Application (2015-2020)
8 China
8.1 China Infantile Spasm Treatment Market Size (2015-2020)
8.2 Infantile Spasm Treatment Key Players in China (2019-2020)
8.3 China Infantile Spasm Treatment Market Size by Type (2015-2020)
8.4 China Infantile Spasm Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Infantile Spasm Treatment Market Size (2015-2020)
9.2 Infantile Spasm Treatment Key Players in Japan (2019-2020)
9.3 Japan Infantile Spasm Treatment Market Size by Type (2015-2020)
9.4 Japan Infantile Spasm Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Infantile Spasm Treatment Market Size (2015-2020)
10.2 Infantile Spasm Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Infantile Spasm Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Infantile Spasm Treatment Market Size by Application (2015-2020)
11 India
11.1 India Infantile Spasm Treatment Market Size (2015-2020)
11.2 Infantile Spasm Treatment Key Players in India (2019-2020)
11.3 India Infantile Spasm Treatment Market Size by Type (2015-2020)
11.4 India Infantile Spasm Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Infantile Spasm Treatment Market Size (2015-2020)
12.2 Infantile Spasm Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Infantile Spasm Treatment Market Size by Type (2015-2020)
12.4 Central & South America Infantile Spasm Treatment Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Mallinckrodt
13.1.1 Mallinckrodt Company Details
13.1.2 Mallinckrodt Business Overview and Its Total Revenue
13.1.3 Mallinckrodt Infantile Spasm Treatment Introduction
13.1.4 Mallinckrodt Revenue in Infantile Spasm Treatment Business (2015-2020))
13.1.5 Mallinckrodt Recent Development
13.2 H. Lundbeck
13.2.1 H. Lundbeck Company Details
13.2.2 H. Lundbeck Business Overview and Its Total Revenue
13.2.3 H. Lundbeck Infantile Spasm Treatment Introduction
13.2.4 H. Lundbeck Revenue in Infantile Spasm Treatment Business (2015-2020)
13.2.5 H. Lundbeck Recent Development
13.3 Insys Therapeutics
13.3.1 Insys Therapeutics Company Details
13.3.2 Insys Therapeutics Business Overview and Its Total Revenue
13.3.3 Insys Therapeutics Infantile Spasm Treatment Introduction
13.3.4 Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020)
13.3.5 Insys Therapeutics Recent Development
13.4 Orphelia Pharma
13.4.1 Orphelia Pharma Company Details
13.4.2 Orphelia Pharma Business Overview and Its Total Revenue
13.4.3 Orphelia Pharma Infantile Spasm Treatment Introduction
13.4.4 Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2015-2020)
13.4.5 Orphelia Pharma Recent Development
13.5 Valerion Therapeutics
13.5.1 Valerion Therapeutics Company Details
13.5.2 Valerion Therapeutics Business Overview and Its Total Revenue
13.5.3 Valerion Therapeutics Infantile Spasm Treatment Introduction
13.5.4 Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020)
13.5.5 Valerion Therapeutics Recent Development
13.6 Catalyst Pharmaceuticals
13.6.1 Catalyst Pharmaceuticals Company Details
13.6.2 Catalyst Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Introduction
13.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020)
13.6.5 Catalyst Pharmaceuticals Recent Development
13.7 Anavex Life Sciences
13.7.1 Anavex Life Sciences Company Details
13.7.2 Anavex Life Sciences Business Overview and Its Total Revenue
13.7.3 Anavex Life Sciences Infantile Spasm Treatment Introduction
13.7.4 Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2015-2020)
13.7.5 Anavex Life Sciences Recent Development
13.8 Retrophin
13.8.1 Retrophin Company Details
13.8.2 Retrophin Business Overview and Its Total Revenue
13.8.3 Retrophin Infantile Spasm Treatment Introduction
13.8.4 Retrophin Revenue in Infantile Spasm Treatment Business (2015-2020)
13.8.5 Retrophin Recent Development
13.9 GW Pharmaceuticals
13.9.1 GW Pharmaceuticals Company Details
13.9.2 GW Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 GW Pharmaceuticals Infantile Spasm Treatment Introduction
13.9.4 GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020)
13.9.5 GW Pharmaceuticals Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Infantile Spasm Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Infantile Spasm Treatment Revenue
Table 3. Ranking of Global Top Infantile Spasm Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Infantile Spasm Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Parenteral
Table 7. Global Infantile Spasm Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Infantile Spasm Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Infantile Spasm Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Infantile Spasm Treatment Market Share by Regions (2015-2020)
Table 11. Global Infantile Spasm Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Infantile Spasm Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Infantile Spasm Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Infantile Spasm Treatment Players
Table 18. Global Infantile Spasm Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Infantile Spasm Treatment Market Share by Players (2015-2020)
Table 20. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasm Treatment as of 2019)
Table 21. Global Infantile Spasm Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Infantile Spasm Treatment Product Solution and Service
Table 24. Date of Enter into Infantile Spasm Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Infantile Spasm Treatment Market Size Share by Type (2015-2020)
Table 28. Global Infantile Spasm Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Infantile Spasm Treatment Market Size Share by Application (2015-2020)
Table 30. Global Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Infantile Spasm Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 34. North America Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 36. North America Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 40. Europe Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 42. Europe Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 46. China Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 48. China Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 52. Japan Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 54. Japan Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 58. Southeast Asia Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 64. India Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 66. India Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Infantile Spasm Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Infantile Spasm Treatment Market Share (2019-2020)
Table 70. Central & South America Infantile Spasm Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Infantile Spasm Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Infantile Spasm Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Infantile Spasm Treatment Market Share by Application (2015-2020)
Table 74. Mallinckrodt Company Details
Table 75. Mallinckrodt Business Overview
Table 76. Mallinckrodt Product
Table 77. Mallinckrodt Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 78. Mallinckrodt Recent Development
Table 79. H. Lundbeck Company Details
Table 80. H. Lundbeck Business Overview
Table 81. H. Lundbeck Product
Table 82. H. Lundbeck Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 83. H. Lundbeck Recent Development
Table 84. Insys Therapeutics Company Details
Table 85. Insys Therapeutics Business Overview
Table 86. Insys Therapeutics Product
Table 87. Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 88. Insys Therapeutics Recent Development
Table 89. Orphelia Pharma Company Details
Table 90. Orphelia Pharma Business Overview
Table 91. Orphelia Pharma Product
Table 92. Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 93. Orphelia Pharma Recent Development
Table 94. Valerion Therapeutics Company Details
Table 95. Valerion Therapeutics Business Overview
Table 96. Valerion Therapeutics Product
Table 97. Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 98. Valerion Therapeutics Recent Development
Table 99. Catalyst Pharmaceuticals Company Details
Table 100. Catalyst Pharmaceuticals Business Overview
Table 101. Catalyst Pharmaceuticals Product
Table 102. Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 103. Catalyst Pharmaceuticals Recent Development
Table 104. Anavex Life Sciences Company Details
Table 105. Anavex Life Sciences Business Overview
Table 106. Anavex Life Sciences Product
Table 107. Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 108. Anavex Life Sciences Recent Development
Table 109. Retrophin Business Overview
Table 110. Retrophin Product
Table 111. Retrophin Company Details
Table 112. Retrophin Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 113. Retrophin Recent Development
Table 114. GW Pharmaceuticals Company Details
Table 115. GW Pharmaceuticals Business Overview
Table 116. GW Pharmaceuticals Product
Table 117. GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2015-2020) (Million US$)
Table 118. GW Pharmaceuticals Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Infantile Spasm Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Parenteral Features
Figure 4. Global Infantile Spasm Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Infantile Spasm Treatment Report Years Considered
Figure 9. Global Infantile Spasm Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Infantile Spasm Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Infantile Spasm Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Infantile Spasm Treatment Market Share by Players in 2019
Figure 14. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasm Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Infantile Spasm Treatment Revenue in 2019
Figure 16. North America Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Infantile Spasm Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Mallinckrodt Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 25. H. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. H. Lundbeck Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 27. Insys Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Insys Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 29. Orphelia Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Orphelia Pharma Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 31. Valerion Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Valerion Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 33. Catalyst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 35. Anavex Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Anavex Life Sciences Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 37. Retrophin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Retrophin Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 39. GW Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed